The School of Dentistry performed outstandingly in REF2014 in its unit of assessment, and ranked 1st in the country for research recognised as internationally excellent (4*/3*).
In addition, 100% of our impact case studies were deemed 4* or 3*, demonstrating that our cutting-edge and high quality research has considerable global influence and reach. Our academics work with leading global industry names such as GSK, Unilever, Philips and Mars to develop new products which not only aim to health oral and dental disease but will have health impacts far beyond the mouth, including diabetes and heart disease treatments. In September 2015, a new £50M state-of-the-art Birmingham Dental Hospital/School, the first new dental hospital in the UK for 40 years, will open.
UPDATE – AUGUST 2015 - Due to a number of challenges with the construction programme, a decision has been taken by all partners to reschedule the opening of the new Birmingham Dental Hospital and School of Dentistry. This has been agreed in order to minimise disruption and maintain continuity of service for patients, students and staff. All partners will be working closely together over the coming weeks to revise the programme of works with a new opening date. Once agreed this will be communicated, it is expected that the new opening date will be known by Welcome week.
Oral infectious and inflammatory diseases are the most common human diseases worldwide and cause significant morbidity, impacting upon general health, wellbeing and mortality rates. Their impact on the national and global economy is substantial. Our research is making significant inroads into understanding their pathobiology and translating this into novel treatments.
The strengths of our internationally-leading teams centre on developing a sound understanding of disease mechanisms to underpin novel evidence-based diagnostics, novel biomarkers and tissue regenerative therapeutic strategies for patient benefit. Our pioneering studies in periodontal diseases, tissue repair and regeneration, oral cancer, pulp and stem cell biology, draw upon interdisciplinary research in cell and molecular biology, biomedical imaging and computational modelling. This work is enhanced by strong local, national and international (Europe, North/South America, Far-East, Asia) collaborations.
Our excellence in the field of tissue repair, regeneration and rehabilitation is underpinned by multi-disciplinary expertise in the biological, physical and biological sciences. Our state-of-the-art laboratories and associated clinics house cutting-edge technologies to formulate and translate new healthcare solutions. Our clinician-basic science partnerships provide the synergies to enable exploitation of our findings through clinical trials in collaboration with our NHS partners.
Our focus on the scientific basis of oral and dental disease is providing innovative solutions to important health issues and is helping us to deliver our vision for improving oral and general well-being.
Our Clinical and Experimental Oral Sciences research encompasses a wide range of areas, which aim to identify and develop new and improved diagnostics and preventative dental treatments for patient benefit. Our internationally leading research is underpinned by patient engagement and we are making significant advances in our understanding of complex oral diseases, which are being translated to impact on whole body well-being.
Our Oral Regeneration and Rehabilitation Sciences research utilises cutting-edge, multidisciplinary approaches to develop new therapies for repairing and rebuilding the human body, which has become damaged due to disease or trauma. Driven by our world class collaborative research, we bring together biological, physical and clinical scientists to develop and translate novel therapeutic technologies.